HR 7265 United States House · 117th Congress

Cerebral Palsy Research Program Authorization Act of 2022

Summary
Cerebral Palsy Research Program Authorization Act of 2022 This bill expands research activities related to cerebral palsy (a group of disorders caused by abnormal brain development or damage that affects an individual's ability to move and maintain balance and posture). Specifically, the Centers for Disease Control and Prevention must carry out a cerebral palsy research program that addresses diagnosis and treatment, public health surveillance, and related matters. Additionally, the National Institute of Neurological Disorders and Stroke and the Eunice Kennedy Shriver National Institute of Child Health and Human Development must update an existing strategic plan for cerebral palsy research.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 29, 2022 Last action Mar 30, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
2
Mar 30, 2022
Committee
Referred to the Subcommittee on Health.
lower
Mar 29, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 29, 2022
Introduced
Introduced in House
lower
1 primary · 5 co-sponsors

Sponsors